Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials

This collaboration is essential to eliminating traditional barriers in patient recruitment and reducing friction when transitioning between development stages and CRO partners, ultimately accelerating the delivery of breakthrough treatments to patients.

This prestigious recognition reflects Lindus’ ongoing commitment to developing adaptive, innovative technology that fixes the broken Contract Research Organization (CRO) model through its all-in-one solution.

Heather Davis joins the executive team, bringing 30 years of experience to continue expanding Lindus Health's footprint in North America.

This collaboration strengthens Lindus’ ability to deliver robust end-to-end clinical trials through one unified solution.

Lindus Health has been able to achieve on average 72.9% faster enrollment across all their studies to date through a vertically integrated approach that breaks the status quo.

This open-label pilot study evaluated the Frieda Menova app—Frieda Health's proprietary digital therapeutic that integrates cognitive behavioral therapy (CBT)—for its effectiveness in alleviating menopausal symptoms, including vasomotor disturbances, sleep disruption, and psychological distress.